in women. Genetic
testing for mutations in the GJB1 gene, including the с.259C>G (р.P87A) mutation, can
KAZANTSEVA, A.V.,
DAVYDOVA, YU.D.,
ENIKEEVA, R.F.,
LOBASKOVA, M.M.,
MUSTAFIN, R.N.,
MALYKH, S.B.,
TAKHIROVA, Z.R.,
KHUSNUTDINOVA, E.K. (2020) ), and AVPR1B (rs33911258) genes, and gene-by-environment interactions were
tested with linear regression
Korytina, G.F.,
Akhmadishina, L.Z.,
Kochetova, O.V.,
Burduk, Yu.V.,
Aznabaeva, Yu.G.,
Zagidullin, Sh.Z.,
Victorova, T.V. (2014) Polymorphisms of the CHRNA5/A3, CYP2A6, NQO1, XPC, XRCC1, CRCC3, XPD, and XPA genes were
testedZhou, Qi,
Zhang, Daming,
Chen, Xin,
Yang, Zhao,
Liu, Zhihui,
Wei, Baixing,
Jin, Mei,
Feng, Kairu,
Guo, Chunmei,
Sun, Junying,
Chen, Sheng,
Zhang, Ruijia,
Piao, Xiai,
Gareev, Ilgiz,
Sun, Zhenying,
Wang, Xiaoxiong,
Li, Lili,
Zhao, Shiguang,
Yang, Guang (2020) was
tested.
Results The proportion of patients with poor functional outcome and mortality at three months
Bogliolo, M.,
Catucci, I.,
Caleca, L.,
Lasheras, S.V.,
Pujol, R.,
Kiiski, J.I.,
Muranen, T.A.,
Barnes, D.R.,
Dennis, J.,
Michailidou, K.,
Bolla, M.K.,
Leslie, G.,
Figlioli, G. (2019) , with greater effects for the ER-negative and triple-negative breast cancer (TNBC) subtypes. We
tested the three
in PLINK software. Multilocus associations were
tested with APSampler 3.6.0 using Markov
chain Monte
was performed using
two-tailed Fisher’s exact
test, odds ratio, 95% confidence interval and logistic
regression
Idrisov, Bulat,
Lunze, Karsten,
Cheng, Debbie M.,
Elena Blokhina,
Gnatienko, Natalia,
Quinn, Emily,
Bridden, Carly,
Walley, Alexander Y.,
Bryant, Kendall J.,
Lioznov, Dmitry,
Krupitsky, Evgeny,
Samet, Jefrey H. (2017) ) and serum
tests (HVL). To examine the primary outcome, we used multiple logistic regression models
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) targeting JNK. In the present study, we have
tested the hypothesis that C66 could prevent obesity